Jul 13, 2026 07:30AM
Jul 13, 2026 05:10AM
May 7, 2026 04:15PM
Mar 20, 2026 06:58AM
Mar 18, 2026 04:09PM
Feb 5, 2026 03:30AM
Jan 12, 2026 07:45AM Stoke Therapeutics (STOK) Reiterated at Overweight by Cantor Fitzgerald
Jan 12, 2026 06:44AM
Jan 5, 2026 07:54AM
Jan 5, 2026 04:34AM
Jan 5, 2026 04:24AM
Dec 16, 2025 06:53AM
Dec 5, 2025 09:01AM
Dec 1, 2025 07:31AM Stoke and Biogen to present zorevunersen data at epilepsy conference
Nov 17, 2025 07:30AM
Nov 4, 2025 05:57PM
Oct 13, 2025 01:34PM
Oct 10, 2025 07:23AM
Oct 9, 2025 04:31PM
Sep 2, 2025 07:03AM
Sep 2, 2025 07:01AM Stoke Therapeutics and Biogen present 3-year zorevunersen data for Dravet
Aug 25, 2025 07:00AM
Aug 18, 2025 05:11AM
Aug 12, 2025 04:04PM
Jul 18, 2025 02:02AM
Jul 14, 2025 06:57AM
Jul 9, 2025 04:04PM
May 15, 2025 06:48AM Stoke Therapeutics (STOK) PT Lowered to $35 at H.C. Wainwright
May 14, 2025 01:54AM
Mar 20, 2025 06:43AM
Mar 18, 2025 07:01AM
Mar 18, 2025 06:58AM
Feb 18, 2025 09:58AM
Feb 18, 2025 08:03AM
Jan 8, 2025 06:36AM Cantor Fitzgerald Reiterates Overweight Rating on Stoke Therapeutics (STOK)
Jan 7, 2025 07:02AM
Dec 5, 2024 07:00AM
Dec 4, 2024 07:01AM
Nov 5, 2024 07:43AM
Oct 9, 2024 04:20PM
Sep 11, 2024 09:10AM
Sep 11, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Stoke Therapeutics (STOK)
Sep 10, 2024 07:02AM
Sep 4, 2024 08:04AM
Jun 13, 2024 04:11PM

418,483 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All